Compare Novo Nordisk A/S (NVO) vs D Wave Quantum Inc (QBTS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novo Nordisk A/S vs D Wave Quantum Inc — how do they compare? Novo Nordisk A/S trades at $49.35 (market cap $220.53B), while D Wave Quantum Inc trades at $17.93 (market cap $6.19B). The key difference: Novo Nordisk A/S is far larger — about 35.6× D Wave Quantum Inc's market cap, and Novo Nordisk A/S pays a 3.63% dividend while D Wave Quantum Inc pays none. Which is the better fit depends on your goals.
| NVO | QBTS | |
|---|---|---|
Market Cap | $220.53B | $6.19B |
Sector | Health | Technology |
52-Week High | $71.70 | $44.78 |
52-Week Low | $35.29 | $12.98 |
Enterprise Value | $239.49B | $5.65B |
Dividend Yield | 3.63% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novo Nordisk A/S
With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Read more on NVO →About D Wave Quantum Inc
D-Wave Quantum Inc. is a global leader in the development and delivery of quantum computing systems, software, and services. The company specializes in annealing quantum computers designed to solve complex optimization problems across industries such as logistics, materials science, and financial modeling. D-Wave offers its technology through the cloud, allowing customers to build and run real-world quantum applications today, making it a key player in the commercialization of quantum computing.
Read more on QBTS →
